Dehaier Medical Systems Ltd  

(Public, NASDAQ:DHRM)   Watch this stock  
Find more results for DHRM
+0.04 (2.37%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.70 - 1.88
52 week 1.22 - 4.29
Open 1.75
Vol / Avg. 0.00/83,934.00
Mkt cap 11.87M
P/E     -
Div/yield     -
EPS -1.15
Shares 6.82M
Beta 1.75
Inst. own 0%

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -285.96% -519.26%
Operating margin -409.46% -536.24%
EBITD margin - -489.39%
Return on average assets -7.81% -39.12%
Return on average equity -14.14% -59.97%
Employees 107 -
CDP Score - -


Room 501 83 Fuxing Road, Haidian District
+86-10-51660080 (Phone)
+86-10-89718090 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Dehaier Medical Systems Limited (Dehaier) is a China-based company that designs, develops and markets its branded products in China. The Company imports the majority of the products and medical components it sells to its customers. The Company designs, develops and markets some of its own medical components that are part of the branded products to be distributed. The Company focuses on the development and distribution of medical devices. In addition to Dehaier’s branded products, it also serves as a distributor of products designed and manufactured by other companies. The Company broadens product portfolio through distribution agreements with international manufacturers. Its distributed offerings are mainly conventional equipments used in the operating room, intensive care unit (ICU) and emergency room.

Officers and directors

Ping Chen Chairman of the Board, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Huili Li Chief Financial Officer, Director
Bio & Compensation  - Reuters
Xiaoguang Shen Director
Age: 42
Bio & Compensation  - Reuters
Genhui Chen PhD Independent Director
Age: 49
Bio & Compensation  - Reuters
Mingwei Zhang Independent Director
Age: 59
Bio & Compensation  - Reuters